Rigel Pharmaceuticals Inc Sustainability Reports
Rigel Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers, develops, and provides small-molecule therapies for patients with hematologic disorders, cancer, and rare immune diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900KPTNUS5J8K9K66
12 reports from 2005 to 2025